"Hearst Magazines and Yahoo may earn commission or revenue on some items through these links." Peptides are all anyone wants ...

The company's new GLP-1 program will offer both oral and injectable medications Courtesy Amazon Amazon has launched a new GLP ...

The company argues the offering is a more comprehensive approach to weight management, allowing patients to receive ongoing ...

Twelve million people lost coverage for Zepbound over the last year. The same number of people lost coverage for Wegovy, ...

With an IPO raise of $625 million, Kailera Therapeutics now holds the new record for the largest public market debut.

Two years ago, Sue Prentiss got a sobering reality check at her doctor’s office. The news was blunt: She qualified for bariatric surgery, a procedure for patients whose weight poses life-threatening ...

A booming online marketplace exists for alternatives to popular weight-loss medications. But these drugs can be risky.

As demand for GLP-1 drugs surges, employers and insurers are struggling to keep up with the cost. Some are dropping coverage ...

The investigators explained that GLP-1 receptor agonists appear to be able to help resolve MASH without worsening fibrosis. Those findings have been confirmed in mouse models and in multiple studies ...

Hims may have an chance to grow peptides business as a potential revenue driver, with FDA review in 2026 shaping the ...

Jim Cramer gave his latest thinking on all 31 stocks owned by the CNBC Investing Club, including Nvidia, Apple, and Microsoft ...

Even as demand for blockbuster GLP-1 weight-loss drugs explodes, Jefferson Health’s own employees are mostly watching from ...